An honest look at treating narrowed kidney arteries — why careful patient selection, not routine stenting, is what actually separates a good outcome from one that doesn't help.
The kidneys receive their blood supply through the renal arteries, which branch directly off the aorta. Renal artery stenosis is a narrowing of one or both of these arteries that reduces blood flow to the kidney. The kidney responds to this reduced flow by activating a hormonal system — the renin-angiotensin pathway — that raises blood pressure throughout the body in an attempt to push more blood through the narrowed vessel. Over time, if the narrowing is severe or affects both kidneys, this same reduced blood flow can also directly damage kidney tissue and impair kidney function.
The two most common causes are quite different in who they affect and how they behave. Atherosclerotic renal artery stenosis, a build-up of plaque similar to that seen in coronary or carotid artery disease, is the more common cause overall and typically affects older adults, often with plaque also present at the origin (ostium) of the renal artery. Fibromuscular dysplasia (FMD), a non-atherosclerotic thickening of the artery wall of unclear cause, more often affects younger women and can respond very differently to treatment.
Poorly controlled on three or more medications, with a significant stenosis and a viable kidney.
Or stenosis in a single functioning kidney, with progressive decline or recurrent pulmonary oedema.
Particularly where medications can't be tolerated to control it.
Which tends to respond considerably more favourably to angioplasty than atherosclerotic disease.
Contrast dye, and sometimes a pressure-wire measurement, confirms the severity of narrowing.
A needle puncture is made at the wrist or groin under local anaesthesia.
A stent (or balloon alone for FMD) holds the artery open.
Most go home the same day or after a short overnight stay.
Renal artery stenosis is frequently silent until it's severe, and is often found incidentally on imaging done for another reason. It should be specifically suspected in a few classic clinical situations:
Resistant hypertension — blood pressure that stays poorly controlled despite three or more medications at full doses, including a diuretic.
A sudden worsening of previously well-controlled blood pressure, or high blood pressure appearing for the first time at an unusually young or old age.
Unexplained decline in kidney function, particularly a rise in creatinine after starting an ACE inhibitor or ARB medication, which can unmask significant renal artery narrowing.
A kidney that's notably smaller than the other one on imaging, without another clear explanation.
Recurrent, otherwise unexplained flash pulmonary oedema — sudden fluid build-up in the lungs — in a patient with preserved heart pumping function.
Duplex ultrasound is typically the first screening test, as it's non-invasive and can estimate the degree of narrowing and blood flow velocity across it. CT angiography or MR angiography give a more detailed anatomical picture and are often used to confirm and plan around a suspected stenosis. Where intervention is being considered, catheter-based angiography — with a pressure measurement across the narrowing when the degree of stenosis is borderline — remains the most definitive way to confirm that a narrowing is severe enough to be genuinely responsible for a patient's blood pressure or kidney problem, since not every narrowing seen on a scan is hemodynamically significant.
This is the central, and most misunderstood, question in renal artery disease. Large randomised trials comparing renal artery stenting with optimal medical therapy alone, in broad or asymptomatic populations, did not show a general benefit of stenting for blood pressure or kidney outcomes — which is why routine stenting of an incidentally found renal artery narrowing is not recommended. Medical therapy — blood pressure medication, a statin, and risk-factor control — remains the mandatory first-line treatment for atherosclerotic renal artery stenosis, with intervention reserved for specific higher-risk scenarios where medical therapy alone has failed or isn't enough:
Resistant hypertension — blood pressure remaining poorly controlled on three or more maximally tolerated medications, with a significant (typically over 70%) stenosis and a kidney that's still viable.
Bilateral renal artery stenosis, or stenosis in a single functioning kidney, with high-risk features such as progressive kidney decline or recurrent flash pulmonary oedema.
Accelerated, resistant, or malignant hypertension with an unexplained small kidney on one side, particularly where the patient can't tolerate the medications needed to control it.
Fibromuscular dysplasia with organ ischaemia, and symptomatic FMD more broadly, since the response to angioplasty tends to be considerably more favourable in FMD than in atherosclerotic disease.
Outside these situations, careful medical management alone is usually the right course, and the decision to intervene is made individually rather than automatically based on the degree of narrowing seen on a scan.
Access: a needle puncture is made in the wrist (radial) or groin (femoral) artery, under local anaesthesia.
Angiography: a catheter is guided to the aorta near the renal artery origins, and contrast dye confirms the location and severity of the narrowing; a pressure-wire measurement may be taken across borderline lesions.
Angioplasty and stenting: for atherosclerotic disease, a balloon is used to open the narrowing and a stent is placed to hold the artery open, since atherosclerotic renal lesions have a high rate of recoil and re-narrowing with balloon angioplasty alone. For fibromuscular dysplasia, balloon angioplasty alone is usually sufficient, and stenting is reserved as a backup if angioplasty alone doesn't adequately open the vessel.
Closure: the puncture site is closed with pressure or a small closure device, and most patients go home the same day or after a short overnight stay.
The whole procedure typically takes under an hour and is done under local anaesthesia with light sedation.
In appropriately selected patients — particularly those with resistant hypertension and a clearly significant stenosis, or younger patients with fibromuscular dysplasia — stenting or angioplasty can meaningfully improve blood pressure control, sometimes allowing a reduction in the number of medications needed, and can stabilise or improve kidney function where decline was directly related to reduced blood flow. Results are far less predictable, and often disappointing, in patients with long-standing, diffuse kidney damage or very small, poorly functioning kidneys, which is exactly why careful patient selection — rather than treating every narrowing seen on a scan — is the single biggest factor separating a good outcome from a procedure that doesn't help.
Because the evidence base for renal artery intervention is more selective than for many other vascular procedures on this site, the value of treatment here comes largely from getting patient selection right — distinguishing a genuinely flow-limiting, treatable stenosis from an incidental finding that's unlikely to be driving the patient's blood pressure or kidney problem. This depends on close coordination between the interventional team and the nephrology or hypertension specialist managing the patient's overall care, since the decision of who should — and shouldn't — be stented is a clinical judgement made jointly, not a default response to an abnormal scan.
No — most don't. Large trials have shown no general benefit of stenting over good medical therapy in broad populations, so treatment is reserved for specific situations such as resistant hypertension, bilateral disease, or fibromuscular dysplasia with symptoms, rather than being based on the degree of narrowing alone.
Atherosclerotic disease is a plaque build-up typically seen in older adults, usually treated with a stent when intervention is needed. Fibromuscular dysplasia is a different kind of arterial wall thickening, more common in younger women, usually treated with balloon angioplasty alone, and often with a better blood-pressure response to treatment.
In some patients — particularly younger patients with fibromuscular dysplasia — it can significantly improve or occasionally normalise blood pressure. In patients with atherosclerotic disease and longer-standing hypertension, the more realistic goal is usually better control with fewer medications, rather than a full cure.
No — it's done through a single needle puncture in the wrist or groin, under local anaesthesia, without any surgical incision.
This depends on the severity of the stenosis, whether it's confirmed to be functionally significant (sometimes with a pressure measurement), how it's affecting your blood pressure or kidney function, and whether it fits one of the specific scenarios where trial evidence supports intervention — which is why a dedicated evaluation matters more here than for many other vascular conditions.
Book a consultation with Dr. Giragani to discuss whether intervention is right for your case.